
OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Tanshinone IIA ameliorates the bleomycin-induced endothelial-to-mesenchymal transition via the Akt/mTOR/p70S6K pathway in a murine model of systemic sclerosis
Ying Jiang, Feifei Hu, Qiao Li, et al.
International Immunopharmacology (2019) Vol. 77, pp. 105968-105968
Closed Access | Times Cited: 21
Ying Jiang, Feifei Hu, Qiao Li, et al.
International Immunopharmacology (2019) Vol. 77, pp. 105968-105968
Closed Access | Times Cited: 21
Showing 21 citing articles:
mTOR Signaling in Pulmonary Vascular Disease: Pathogenic Role and Therapeutic Target
Aleksandra Babicheva, Ayako Makino, Jason X.‐J. Yuan
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 4, pp. 2144-2144
Open Access | Times Cited: 42
Aleksandra Babicheva, Ayako Makino, Jason X.‐J. Yuan
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 4, pp. 2144-2144
Open Access | Times Cited: 42
A comprehensive review of tanshinone IIA and its derivatives in fibrosis treatment
Zhangyang Bi, Yayun Wang, Caiqing Zhang
Biomedicine & Pharmacotherapy (2021) Vol. 137, pp. 111404-111404
Open Access | Times Cited: 38
Zhangyang Bi, Yayun Wang, Caiqing Zhang
Biomedicine & Pharmacotherapy (2021) Vol. 137, pp. 111404-111404
Open Access | Times Cited: 38
Endothelial-to-mesenchymal transition in systemic sclerosis
Paola Di Benedetto, Piero Ruscitti, Onorina Berardicurti, et al.
Clinical & Experimental Immunology (2021) Vol. 205, Iss. 1, pp. 12-27
Open Access | Times Cited: 37
Paola Di Benedetto, Piero Ruscitti, Onorina Berardicurti, et al.
Clinical & Experimental Immunology (2021) Vol. 205, Iss. 1, pp. 12-27
Open Access | Times Cited: 37
Elevated interleukin‐11 in systemic sclerosis and role in disease pathogenesis
Thomas Steadman, Steven O’Reilly
The Journal of Dermatology (2023) Vol. 50, Iss. 10, pp. 1255-1261
Open Access | Times Cited: 14
Thomas Steadman, Steven O’Reilly
The Journal of Dermatology (2023) Vol. 50, Iss. 10, pp. 1255-1261
Open Access | Times Cited: 14
The role and mechanism of JAK2 inhibitor in endothelial mesenchymal transition in systemic sclerosis
Qingyan Luo, Xiaoheng Wang, Yanling Zhang, et al.
Journal of Dermatological Science (2025)
Closed Access
Qingyan Luo, Xiaoheng Wang, Yanling Zhang, et al.
Journal of Dermatological Science (2025)
Closed Access
The contribution of endothelial cells to tissue fibrosis
Eloisa Romano, Irene Rosa, Bianca Saveria Fioretto, et al.
Current Opinion in Rheumatology (2023) Vol. 36, Iss. 1, pp. 52-60
Open Access | Times Cited: 12
Eloisa Romano, Irene Rosa, Bianca Saveria Fioretto, et al.
Current Opinion in Rheumatology (2023) Vol. 36, Iss. 1, pp. 52-60
Open Access | Times Cited: 12
Recent Insights into Cellular and Molecular Mechanisms of Defective Angiogenesis in Systemic Sclerosis
Eloisa Romano, Irene Rosa, Bianca Saveria Fioretto, et al.
Biomedicines (2024) Vol. 12, Iss. 6, pp. 1331-1331
Open Access | Times Cited: 4
Eloisa Romano, Irene Rosa, Bianca Saveria Fioretto, et al.
Biomedicines (2024) Vol. 12, Iss. 6, pp. 1331-1331
Open Access | Times Cited: 4
Natural products in traditional Chinese medicine for renal fibrosis: a comprehensive review
Qianqian Zhao, Meihua Jin, Qiang Zhao, et al.
Frontiers in Pharmacology (2025) Vol. 16
Open Access
Qianqian Zhao, Meihua Jin, Qiang Zhao, et al.
Frontiers in Pharmacology (2025) Vol. 16
Open Access
New Insights into Profibrotic Myofibroblast Formation in Systemic Sclerosis: When the Vascular Wall Becomes the Enemy
Eloisa Romano, Irene Rosa, Bianca Saveria Fioretto, et al.
Life (2021) Vol. 11, Iss. 7, pp. 610-610
Open Access | Times Cited: 25
Eloisa Romano, Irene Rosa, Bianca Saveria Fioretto, et al.
Life (2021) Vol. 11, Iss. 7, pp. 610-610
Open Access | Times Cited: 25
<p>Resveratrol Ameliorates Systemic Sclerosis via Suppression of Fibrosis and Inflammation Through Activation of SIRT1/mTOR Signaling</p>
Qicen Yao, Qingchao Wu, Xiayu Xu, et al.
Drug Design Development and Therapy (2020) Vol. Volume 14, pp. 5337-5348
Open Access | Times Cited: 26
Qicen Yao, Qingchao Wu, Xiayu Xu, et al.
Drug Design Development and Therapy (2020) Vol. Volume 14, pp. 5337-5348
Open Access | Times Cited: 26
The protective effect of tanshinone IIa on endothelial cells: a generalist among clinical therapeutics
Jun Feng, Lina Liu, Fangfang Yao, et al.
Expert Review of Clinical Pharmacology (2021) Vol. 14, Iss. 2, pp. 239-248
Closed Access | Times Cited: 22
Jun Feng, Lina Liu, Fangfang Yao, et al.
Expert Review of Clinical Pharmacology (2021) Vol. 14, Iss. 2, pp. 239-248
Closed Access | Times Cited: 22
Enhanced Sestrin expression through Tanshinone 2A treatment improves PI3K-dependent inhibition of glioma growth
Judith Schaf, Sonia Shinhmar, Qingyu Zeng, et al.
Cell Death Discovery (2023) Vol. 9, Iss. 1
Open Access | Times Cited: 8
Judith Schaf, Sonia Shinhmar, Qingyu Zeng, et al.
Cell Death Discovery (2023) Vol. 9, Iss. 1
Open Access | Times Cited: 8
Exosomal miR ‐126‐3p: Potential protection against vascular damage by regulating the SLC7A5 /mTOR Signalling pathway in human umbilical vein endothelial cells
Ke Zhu, Chen Liu, Xiaofang Guo, et al.
Scandinavian Journal of Immunology (2024) Vol. 99, Iss. 4
Closed Access | Times Cited: 2
Ke Zhu, Chen Liu, Xiaofang Guo, et al.
Scandinavian Journal of Immunology (2024) Vol. 99, Iss. 4
Closed Access | Times Cited: 2
A Skin Lipidomics Study Reveals the Therapeutic Effects of Tanshinones in a Rat Model of Acne
Tingting Chen, Zhaoming Zhu, Qunqun Du, et al.
Frontiers in Pharmacology (2021) Vol. 12
Open Access | Times Cited: 17
Tingting Chen, Zhaoming Zhu, Qunqun Du, et al.
Frontiers in Pharmacology (2021) Vol. 12
Open Access | Times Cited: 17
Knockdown of circHECTD1 inhibits oxygen-glucose deprivation and reperfusion induced endothelial-mesenchymal transition
Guohua He, Zhen Wang, Wei Xu, et al.
Metabolic Brain Disease (2022) Vol. 37, Iss. 2, pp. 427-437
Closed Access | Times Cited: 9
Guohua He, Zhen Wang, Wei Xu, et al.
Metabolic Brain Disease (2022) Vol. 37, Iss. 2, pp. 427-437
Closed Access | Times Cited: 9
Linagliptin ameliorates pulmonary fibrosis in systemic sclerosis mouse model via inhibition of endothelial-to-mesenchymal transition
Biwei Pei, Na Zhang, Tingting Pang, et al.
Molecular and Cellular Biochemistry (2022) Vol. 477, Iss. 4, pp. 995-1007
Open Access | Times Cited: 8
Biwei Pei, Na Zhang, Tingting Pang, et al.
Molecular and Cellular Biochemistry (2022) Vol. 477, Iss. 4, pp. 995-1007
Open Access | Times Cited: 8
Tanshinone IIA regulates fibroblast proliferation and migration and post-surgery arthrofibrosis through the autophagy-mediated PI3K and AMPK-mTOR signaling pathway.
Zhen Zhang, Dongming Zhu, Xiaobo Zhang, et al.
American Journal of Translational Research (2021) Vol. 13, Iss. 2, pp. 565-584
Closed Access | Times Cited: 7
Zhen Zhang, Dongming Zhu, Xiaobo Zhang, et al.
American Journal of Translational Research (2021) Vol. 13, Iss. 2, pp. 565-584
Closed Access | Times Cited: 7
Bone morphogenetic protein-7 inhibits endothelial-to-mesenchymal transition in primary human umbilical vein endothelial cells and mouse model of systemic sclerosis via Akt/mTOR/p70S6K pathway
Chen Shen, Ying Jiang, Qiao Li, et al.
Journal of Dermatological Science (2021) Vol. 103, Iss. 2, pp. 82-92
Closed Access | Times Cited: 6
Chen Shen, Ying Jiang, Qiao Li, et al.
Journal of Dermatological Science (2021) Vol. 103, Iss. 2, pp. 82-92
Closed Access | Times Cited: 6
Tanshinone IIA ameliorates the development of dermal fibrosis in systemic sclerosis
Y.L. Jiang, Feifei Hu, Ming Li, et al.
Clinical and Experimental Pharmacology and Physiology (2023) Vol. 51, Iss. 2
Open Access | Times Cited: 2
Y.L. Jiang, Feifei Hu, Ming Li, et al.
Clinical and Experimental Pharmacology and Physiology (2023) Vol. 51, Iss. 2
Open Access | Times Cited: 2
Dangui Huoxue Preparation (DHP) Ameliorates Skin Fibrosis, Inflammation, and Vasculopathy in the Bleomycin‐Induced Murine Model of Systemic Sclerosis
Yue-Mei Yan, Dianyu Cao, Ji‐An Liang, et al.
Advanced Biology (2023) Vol. 8, Iss. 1
Open Access | Times Cited: 1
Yue-Mei Yan, Dianyu Cao, Ji‐An Liang, et al.
Advanced Biology (2023) Vol. 8, Iss. 1
Open Access | Times Cited: 1
Wenyang Huazhuo Tongluo formula alleviates pulmonary vascular injury and downregulates HIF-1α in bleomycin-induced systemic sclerosis mouse model
Kai Li, Qian Wang, Qin Lv, et al.
BMC Complementary Medicine and Therapies (2022) Vol. 22, Iss. 1
Open Access | Times Cited: 2
Kai Li, Qian Wang, Qin Lv, et al.
BMC Complementary Medicine and Therapies (2022) Vol. 22, Iss. 1
Open Access | Times Cited: 2
Enhanced Sestrin expression through Tanshinone 2A treatment improves PI3K-dependent inhibition of glioma growth
Robin S. B. Williams, Judith Schaf, Sonia Shinhmar, et al.
Research Square (Research Square) (2022)
Open Access | Times Cited: 1
Robin S. B. Williams, Judith Schaf, Sonia Shinhmar, et al.
Research Square (Research Square) (2022)
Open Access | Times Cited: 1